Overcoming anti-PD-1/PD-L1 immune checkpoint blockade resistance: the role of macrophage, neutrophils and mast cells in the tumor microenvironment
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10238-023-01059-4.pdf
Reference124 articles.
1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.
2. Schlueter M, Chan K, Lasry R, Price M. The cost of cancer—a comparative analysis of the direct medical costs of cancer and other major chronic diseases in Europe. PLoS One. 2020;15(11).
3. Debela DT, Muzazu SG, Heraro KD, et al. New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med. 2021;9:205031212110343.
4. Shadbad MA, Safaei S, Brunetti O, et al. A systematic review on the therapeutic potentiality of pd-l1-inhibiting micrornas for triple-negative breast cancer: toward single-cell sequencing-guided biomimetic delivery. Genes. 2021;12.
5. Kalkusova K, Smite S, Darras E, et al. Mast cells and dendritic cells as cellular immune checkpoints in immunotherapy of solid tumors. Int J Mol Sci. 2022; 23(19).
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Deficiency of Stabilin-1 in the Context of Hepatic Melanoma Metastasis;Cancers;2024-01-19
2. Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review;International Journal of Biological Macromolecules;2024-01
3. Genetic alterations shape innate immune cells to foster immunosuppression and cancer immunotherapy resistance;Clinical and Experimental Medicine;2023-11-01
4. Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma;Biomedicines;2023-10-06
5. Intracellular DNA sensing by neutrophils and amplification of the innate immune response;Frontiers in Immunology;2023-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3